Moderna

COVID-19: Health Min. offers non-mRNA vaccine, alt. for Pfizer, Moderna

It has obtained supplies of Nuvaxovid from the Novavax company. It is a vaccine that protects against serious complications of the pandemic without being based on mRNA.

EU regulator backs two Omicron-adapted COVID boosters

Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.

By REUTERS
01/09/2022

Pfizer, Moderna's COVID-19 Omicron vaccine boosters approved by US FDA

Pfizer said it has some doses ready to ship immediately and can deliver up to 15 million doses by September 9.

By REUTERS
31/08/2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in thi

US to move COVID-19 vaccines, treatments to private markets in 2023

US President Joe Biden's administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by January.

By REUTERS
31/08/2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in thi

Moderna sues Pfizer and BioNTech over COVID-19 vaccine

Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology.

European Medicines Agency recommends Novavax add warning to their COVID-19 vaccine

The European Medicines Agency (EMA) is recommending that Novavax should start putting a warning label on their COVID-19 vaccines due to a small number of reported cases of heart inflammation.

By REUTERS
03/08/2022
A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

COVID-19 booster shots are crucial, according to a Yale study

New study by Yale, UNC, shows that peak antibody levels achieved by getting vaccinated with an mRNA vaccine exceed those gained from natural infection.

CDC recommends Moderna's COVID vaccine for children 6 months-5 years

President Joe Biden's administration plans to roll out the vaccines to the under-5 age groups as early as next week.

By REUTERS
18/06/2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in thi

Moderna files for US authorization of COVID shot for kids under 6

Moderna released trial data in March showing that its vaccine was safe and generated a similar immune response in young children as for adults.

By REUTERS
28/04/2022

Moderna recalls thousands of COVID vaccine doses in Europe

No safety issues have been identified, Moderna said about the lots that were distributed in Norway, Poland, Portugal, Spain and Sweden in January.

By REUTERS
08/04/2022
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy